N.N-Dimethyl-carbamidsaeure-cyclohexylester | 7541-19-7

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: N.N-Dimethyl-carbamidsaeure-cyclohexylester
• 英文别名: cyclohexyl N,N-dimethylcarbamate
• CAS: 7541-19-7
• 化学式: C₉H₁₇NO₂
• 分子量: 171.239
• InChiKey: MSLVDDNWZVDSHU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  29.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  N.N-Dimethyl-carbamidsaeure-cyclohexylester 生成 环己烯
  参考文献：
  名称：

  Formation of olefins in the pyrolysis of N,N-disubstituted carbamates

  摘要：

  DOI：

  10.1021/jo00326a044
• 作为产物：
  描述：

  二甲氨基甲酰氯 、 环己醇 以 吡啶 为溶剂， 以60%的产率得到N.N-Dimethyl-carbamidsaeure-cyclohexylester
  参考文献：
  名称：

  Formation of olefins in the pyrolysis of N,N-disubstituted carbamates

  摘要：

  DOI：

  10.1021/jo00326a044

文献信息

• Alkali-metal-assisted transfer of the carbamate group from phosphocarbamates to alkyl halides: a new easy way to alkali-metal carbamates and to carbamate esters
  作者：Michele Aresta、Eugenio Quaranta

  DOI：10.1039/dt9920001893

  日期：——

  P(NR2)3, have been used as a source of carbamate groups in the reaction with alkyl halides, R′X, to afford carbamate esters. The reaction is mediated by alkali-metal halides, MY, and requires the presence of a suitable macrocyclic polyether (L). The overall reaction occurs in two steps: the carbamic group is first transferred to the alkali-metal cation to give a carbamate salt [ML][O2CNR2] which then reacts

  磷酸氨基甲酸酯P（O 2 CNR 2）x（NR 2）3 – x（R =烷基；x = 1或2），可通过将CO 2插入相应氨基膦P（NR 2）的P–N键中而容易地获得。在与烷基卤化物R'X的反应中，已经使用图3中的氨基甲酸酯作为氨基甲酸酯基团的来源，以提供氨基甲酸酯。该反应由碱金属卤化物MY介导，并且需要存在合适的大环聚醚（L）。整个反应分为两个步骤：将氨基甲酸酯基团首先转移到碱金属阳离子上，得到氨基甲酸酯盐[ML] [O 2 CNR 2然后与卤代烷反应，得到R 2 NC（O）OR'。氨基甲酸酯的产率和选择性受MY的性质的显着影响。在整个过程中的碱金属盐和大环配体在修改所述R的反应性的作用的性质的影响2 NCO 2 -阴离子中的碱金属的氨基甲酸酯进行了讨论。
• [EN] SUBSTITUTED CYCLIC HYDROXAMATES AS INHIBITORS OF MATRIX METALLOPROTEINASES<br/>[FR] INHIBITEURS DE METALLOPROTEASES MATRICES A BASE D'HYDROXAMATES CYCLIQUES SUBSTITUES
  申请人：INCYTE CORP

  公开号：WO2005037826A1

  公开（公告）日：2005-04-28

  The present invention provides compounds of the formula I: its enantiomers, diastereomers, racemic mixtures thereof, prodrugs, crystalline forms, non-crystalline forms, amorphous forms thereof, solvates thereof, metabolites thereof, and pharmaceutically acceptable salts, wherein the ring A substituent groups are fully defined in the following disclosure. The compounds of formula I are inhibitors of metalloproteases such as matrix metalloproteases and sheddases, and are useful in treating diseases such as rheumatoid arthritis, psoriasis, neoplastic diseases, allergies and all those diseases wherein inhibition of MMPs is desirable.

  本发明提供了公式I的化合物：其对映异构体，二对映异构体，混合物，前药，结晶形式，非晶形式，无定形形式，溶剂化物，代谢物和药学上可接受的盐，其中环A取代基在以下披露中被完全定义。公式I的化合物是金属蛋白酶抑制剂，如基质金属蛋白酶和剪切酶的抑制剂，并且在治疗风湿性关节炎，牛皮癣，肿瘤性疾病，过敏和所有需要MMPs抑制的疾病中有用。
• CYCLOHEXYL CARBAMATE COMPOUNDS AS SKIN AND/OR HAIR LIGHTENING ACTIVES
  申请人：Vielhaber Gabriele

  公开号：US20130156710A1

  公开（公告）日：2013-06-20

  The present invention relates to the cosmetic, dermatological or therapeutic use of certain cyclohexyl carbamate compounds of formula (I) given below, preferably as skin and/or hair lightening (whitening) actives. The invention further relates to compositions and cosmetic, dermatological or therapeutic products comprising one or more compounds of formula (I) suitable for lightening human skin and/or hair and corresponding methods. The invention further relates to compounds of formula (I) as a drug, their use for the preparation of a pharmaceutical composition for lightening human skin and/or hair and to novel compounds of formula (I) wherein A denotes wherein X, Y and Z independently of one another denote hydrogen, C1-C4-alkyl or C2-C4-alkenyl, wherein optionally two of the radicals X, Y and Z are covalently bonded to one another under formation of a bicyclic ring system, in such a bicyclic ring system two of the radicals X, Y and Z together preferably form a radical having 1 to 4 carbon atoms, preferably a hydrocarbon radical having 1 to 3 carbon atoms, B denotes NR 1 , R 2 , wherein R 1 denotes hydrogen or an organic radical having 1 to 14 carbon atoms, R 2 denotes an organic radical having 1 to 14 carbon atoms, and wherein optionally R 1 and R 2 are covalently bonded to one another, preferably so that B is a 3 to 8 membered ring.

  本发明涉及以下式子(I)所示的某些环己基氨基甲酸酯化合物的化妆品、皮肤学或治疗用途，优选作为皮肤和/或头发美白活性剂。本发明还涉及含有一个或多个式(I)化合物的组合物和化妆品、皮肤学或治疗产品，适用于美白人类皮肤和/或头发以及相应的方法。本发明还涉及式(I)化合物作为药物，其用于制备用于美白人类皮肤和/或头发的制药组合物，以及式(I)的新化合物，其中A表示其中X、Y和Z彼此独立地表示氢、C1-C4烷基或C2-C4烯基，其中可选地，X、Y和Z中的两个基团在形成二环环系的情况下共价键结在一起，这样，在这样的二环环系中，X、Y和Z中的两个基团首选形成具有1到4个碳原子的基团，优选为具有1到3个碳原子的碳氢基团；B表示NR1、R2，其中R1表示氢或具有1到14个碳原子的有机基团，R2表示具有1到14个碳原子的有机基团，可选地，R1和R2彼此共价键结，优选使得B为3到8个成员的环。
• Cyclohexyl carbamate compounds as anti-ageing actives
  申请人：Symrise AG

  公开号：EP2389922A1

  公开（公告）日：2011-11-30

  The present invention relates to the cosmetic, dermatological or therapeutic use of compounds of formula (I) given below, in particular as anti-ageing actives. wherein A denotes wherein X, Y and Z independently of one another denote hydrogen, C1-C4-alkyl or C2-C4-alkenyl, wherein optionally two of the radicals X, Y and Z are covalently bonded to one another under formation of a bicyclic ring system, in such a bicyclic ring system two of the radicals X, Y and Z together preferably form a radical having 1 to 4 carbon atoms, preferably a hydrocarbon radical having 1 to 3 carbon atoms, B denotes NR1R2, wherein R1 denotes hydrogen or an organic radical having 1 to 14 carbon atoms, R2 denotes an organic radical having 1 to 14 carbon atoms, and wherein optionally R1 and R2 are covalently bonded to one another, preferably so that B is a 3 to 8 membered ring. The invention further relates to corresponding methods and to compositions and cosmetic, dermatological or pharmaceutical preparations (compositions) comprising one or more compounds of formula (I) and one or more further anti-ageing actives. The invention further relates to compounds of formula (I) as a drug, their use for the preparation of a pharmaceutical composition and to certain novel compounds of formula (I).

  本发明涉及以下式子(I)的化合物在化妆品、皮肤科或治疗中的使用，特别是作为抗衰老活性物质。 其中， A代表 其中，X、Y和Z分别独立地表示氢、C1-C4烷基或C2-C4烯基， 其中，可选地，X、Y和Z中的两个基团在形成二环环系的同时共价键合在一起，这样，在这样的二环环系中，X、Y和Z中的两个基团一起优选形成具有1到4个碳原子的基团，优选是指1到3个碳原子的碳氢基团， B代表NR1R2， 其中， R1代表氢或具有1到14个碳原子的有机基团， R2代表具有1到14个碳原子的有机基团， 并且可选地，R1和R2共价键合在一起，优选是使B成为3到8成员环。 本发明还涉及相应的方法、包含一个或多个式(I)化合物和一个或多个进一步的抗衰老活性物质的组合物和化妆品、皮肤科或制药制剂(组合物)。本发明还涉及式(I)化合物作为药物、其用于制备制药组合物以及某些新的式(I)化合物。
• NONAQUEOUS ELECTROLYTE SOLUTION FOR BATTERIES AND LITHIUM SECONDARY BATTERY
  申请人：Mitsui Chemicals, Inc.

  公开号：EP3051619A1

  公开（公告）日：2016-08-03

  Anon-aqueous electrolyte solution for a battery includes: an additive A which is a compound represented by formula (I); and an additive B which is at least one selected from the group consisting of an aromatic compound having at least one of a halogen atom or an alkyl group and a carbamate, and which is a compound other than carbonates or a cyclic sulfates. In formula (I), R1 represents a group represented by formula (II) or a group represented by formula (III) and R2 represents H, a C1-6 alkyl group, a group represented by formula (II), or a group represented by formula (III); or R1 and R2 represent groups which combine to form a benzene ring or cyclohexyl ring. In formula (II), R3 represents a halogen atom, a C1-6 alkyl group, a C1-6 alkyl halide group, a C1-6 alkoxy group, or a group represented by formula (IV).

  用于电池的非水电解质溶液包括：添加剂 A，它是一种由式（I）表示的化合物；添加剂 B，它是至少一种选自具有卤素原子或烷基中至少一个的芳香族化合物和氨基甲酸酯组成的组的化合物，它是碳酸盐或环硫酸盐以外的化合物。在式 (I) 中，R1 代表式 (II) 所代表的基团或式 (III) 所代表的基团，R2 代表 H、C1-6 烷基、式 (II) 所代表的基团或式 (III) 所代表的基团；或 R1 和 R2 代表结合形成苯环或环己基环的基团。在式 (II) 中，R3 代表卤原子、C1-6 烷基、C1-6 烷基卤化物基团、C1-6 烷氧基或式 (IV) 所代表的基团。